Advertiser / Brand
Haleon vs Kenvue
Structured technology and market comparison · 2026
Direct Feature Comparison
Haleon · vs · KenvuePublic consumer healthcare brand owner focused on everyday health.
Public consumer health brand owner spun out from Johnson & Johnson.
Analyze all overlapping signals and tech stacks for Haleon and Kenvue
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Haleon and Kenvue?
When comparing Haleon and Kenvue, both platforms operate within the Advertiser / Brand ecosystem. Haleon is positioned as Public consumer healthcare brand owner focused on everyday health, whereas Kenvue focuses on Public consumer health brand owner spun out from Johnson & Johnson. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Haleon and Kenvue?
When evaluating Haleon and Kenvue, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Haleon and Kenvue compare?
Haleon is headquartered in United Kingdom (founding year unrecorded) with >5,000 employees. Kenvue is based in United States (founded in 2023) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Haleon vs Kenvue
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Haleon
Recent Signals
No recent market signals documented for Haleon in the current tracking window.
Kenvue
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kenvue (2026-11-04)
On November 4, 2026, Kenvue LLC (as successor in interest to Kenvue Inc.) announced the settlement of exchange offers and consent solicitations conducted by Kimberly-Clark Corporation. Kimberly-Clark exchanged up to $7.0 billion aggregate principal amount of newly issued notes and cash for outstanding Kenvue senior notes across seven series maturing between 2028 and 2063. In total, approximately $6.38 billion aggregate principal amount of Kenvue Notes were validly tendered, accepted, and retired, leaving approximately $624.0 million outstanding across the seven series. Concurrent with the exchange, the Kenvue Third Supplemental Indenture became operative, substantially eliminating restrictive covenants, certain events of default, SEC reporting obligations, and merger/asset transfer restrictions under the Kenvue Indenture. Additionally, following an NYSE Form 25-NSE filing on November 2, 2026, Kenvue's common stock will be formally delisted on November 12, 2026, marking the post-acquisition integration of Kenvue under Kimberly-Clark.
- Kimberly-Clark accepted and cancelled $6,376,039,000 aggregate principal amount of Kenvue Notes across seven tranches, leaving $623,961,000 outstanding.
- The Third Supplemental Indenture stripped the Kenvue Indenture of substantially all restrictive covenants, SEC reporting requirements, and merger/asset transfer limits.
- Following an NYSE Form 25-NSE filing on November 2, 2026, Kenvue's Common Stock will be delisted from the New York Stock Exchange effective November 12, 2026.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kenvue (2026-11-02)
On November 2, 2026, Kenvue Inc. completed its merger with Kimberly-Clark Corporation (K-C), becoming a direct, wholly owned subsidiary named Kenvue LLC. Under the terms of the merger agreement, each share of Kenvue common stock was converted into the right to receive 0.14625 shares of K-C common stock plus $3.50 in cash. In connection with the closing, Kenvue terminated its $4.0 billion revolving credit agreement with JPMorgan Chase Bank, N.A., under which no borrowings were outstanding. Kenvue's entire 12-member board of directors resigned, and common stock was requested to be delisted from the New York Stock Exchange. Additionally, Kenvue LLC entered into a Fourth Supplemental Indenture assuming all obligations under seven tranches of outstanding senior notes aggregating $7.0 billion.
- Kenvue common stock converted into 0.14625 shares of Kimberly-Clark common stock plus $3.50 in cash per share, resulting in the delisting of KVUE from the NYSE.
- Kenvue terminated its $4.0 billion senior unsecured revolving credit facility with JPMorgan Chase Bank, N.A., having zero borrowings outstanding at closing.
- Kenvue LLC formally assumed obligations on $7.0 billion in total aggregate principal across seven series of outstanding senior notes due between 2028 and 2063.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kenvue (2026-10-30)
Kenvue Inc. filed a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition) on October 30, 2026, announcing its financial results for the fiscal third quarter ended September 27, 2026. The full quarterly financial release was furnished as Exhibit 99.1. The filing serves as the formal SEC disclosure vehicle for the company's third-quarter earnings release, signed by Interim Chief Financial Officer and Chief Accounting Officer Heather Howlett.
- Kenvue furnished its fiscal third-quarter financial results for the period ended September 27, 2026 via Exhibit 99.1 on October 30, 2026.
- The filing is furnished pursuant to Item 2.02 and is not deemed filed under Section 18 of the Securities Exchange Act of 1934.
- The Form 8-K was executed by Heather Howlett in her capacity as Interim Chief Financial Officer and Chief Accounting Officer.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Haleon and Kenvue share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks